OpenURL Connection Search

Select item for more details and to access through your institution.

Bacterial flagellin is a dominant antigen in Crohn disease.
Published in:
2004
By:
- Lodes, Michael J.;
- Cong, Yingzi;
- Elson, Charles O.;
- Mohamath, Raodoh;
- Landers, Carol J.;
- Targan, Stephan R.;
- Fort, Madeline;
- Hershberg, Robert M.
Publication type:
journal article
The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes.
Published in:
PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058164
By:
- Dowling, David J.;
- Tan, Zhen;
- Prokopowicz, Zofia M.;
- Palmer, Christine D.;
- Matthews, Maura-Ann H.;
- Dietsch, Gregory N.;
- Hershberg, Robert M.;
- Levy, Ofer
Publication type:
Article
Molecular Approaches to the Role of the Microbiota in Inflammatory Bowel Disease.
Published in:
Annals of the New York Academy of Sciences, 2006, v. 1072, n. 1, p. 39, doi. 10.1196/annals.1326.010
By:
- ELSON, CHARLES O.;
- CONG, YINGZI;
- QI, FENGXIA;
- HERSHBERG, ROBERT M.;
- TARGAN, STEPHAN R.
Publication type:
Article
Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.
Published in:
2006
By:
- Rini, Brian I;
- Weinberg, Vivian;
- Fong, Lawrence;
- Conry, Shauna;
- Hershberg, Robert M;
- Small, Eric J
Publication type:
journal article
Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapyDendreon provided APC8015 (Provenge) for the clinical trial herein, but the IND was held by the Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute, and data analysis was performed by Rini et al.
Published in:
Cancer (0008543X), 2006, v. 107, n. 1, p. 67
By:
- Brian I. Rini;
- Vivian Weinberg;
- Lawrence Fong;
- Shauna Conry;
- Robert M. Hershberg;
- Eric J. Small
Publication type:
Article
VTX-1463, a novel TLR-8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs.
Published in:
Immunity, Inflammation & Disease, 2016, v. 4, n. 1, p. 45, doi. 10.1002/iid3.91
By:
- Royer, Christopher M.;
- Rudolph, Karin;
- Dietsch, Gregory N.;
- Hershberg, Robert M.;
- Barrett, Edward G.
Publication type:
Article
Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity.
Published in:
PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148764
By:
- Dietsch, Gregory N.;
- Lu, Hailing;
- Yang, Yi;
- Morishima, Chihiro;
- Chow, Laura Q.;
- Disis, Mary L.;
- Hershberg, Robert M.
Publication type:
Article
Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma.
Published in:
NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00185-0
By:
- Wall, Matthew A.;
- Turkarslan, Serdar;
- Wu, Wei-Ju;
- Danziger, Samuel A.;
- Reiss, David J.;
- Mason, Mike J.;
- Dervan, Andrew P.;
- Trotter, Matthew W. B.;
- Bassett, Douglas;
- Hershberg, Robert M.;
- Lomana, Adrián López García de;
- Ratushny, Alexander V.;
- Baliga, Nitin S.
Publication type:
Article
Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression.
Published in:
American Journal of Gastroenterology (Springer Nature), 2006, v. 101, n. 2, p. 360, doi. 10.1111/j.1572-0241.2006.00456.x
By:
- Dubinsky, Marla C.;
- Ying-Chao Lin;
- Dutridge, Debra;
- Picornell, Yoana;
- Landers, Carol J.;
- Farrior, Sharmayne;
- Wrobel, Iwona;
- Quiros, Antonio;
- Vasiliauskas, Eric A.;
- Grill, Bruce;
- Israel, David;
- Bahar, Ron;
- Christie, Dennis;
- Wahbeh, Ghassan;
- Silber, Gary;
- Dallazadeh, Saied;
- Shah, Praful;
- Thomas, Danny;
- Kelts, Drew;
- Hershberg, Robert M.
Publication type:
Article

Found: 9